Bleeding into the brain was uncommon, occurring in 0.2% (1 in 500) of patients treated with Xigris.
Veritsust ajju esines aeg- ajalt, 0, 2% - l (1- l patsiendil 500- st) Xigris`ega ravitud patsientidest.